Advances in the treatment of heart failure with preserved ejection fraction

Abstract

Heart failure is a common condition that affects the elderly and is becoming the most common cause of hospitalization among the elderly nowadays. Its incidence has been increasing throughout the years and in particular HFpEF. The challenge with HFpEF lies in its treatment because, unlike HFrEF, the treatments for HFpEF have failed to show significant improvements in this group of patients. Many drug classes have been used for decades, but unfortunately with no significant improvements. Some newer drugs have been introduced recently and these drugs are discussed in detail in this work.